{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:19:08Z","timestamp":1784146748376,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clml.2025.11.008","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T07:07:25Z","timestamp":1763881645000},"page":"e376-e384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dismal Outcome of EBV-Positive Nodal T\/NK-Cell Lymphoma: A Multicenter Retrospective Study"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-7197","authenticated-orcid":false,"given":"Satoshi","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2682-2179","authenticated-orcid":false,"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Katsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fukatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayo","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-7442","authenticated-orcid":false,"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2025.11.008_bib0001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clml.2025.11.008_bib0002","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/CCO.0000000000000889","article-title":"EBV-associated NK and T-cell lymphoid neoplasms","volume":"34","author":"Kimura","year":"2022","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clml.2025.11.008_bib0003","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3324\/haematol.2021.280003","article-title":"Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS","volume":"107","author":"Wai","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2025.11.008_bib0004","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.11.008_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2025.11.008_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3960\/jslrt.20001","article-title":"Nodal EBV+ cytotoxic T-cell lymphoma: a literature review based on the 2017 WHO classification","volume":"60","author":"Kato","year":"2020","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.clml.2025.11.008_bib0007","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2025.11.008_bib0008","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2169\/internalmedicine.4672-24","article-title":"Successful allogeneic hematopoietic stem cell transplantation for nodal Epstein-Barr virus-positive T\/NK-cell lymphoma","volume":"64","author":"Ichikawa","year":"2025","journal-title":"Intern Med"},{"key":"10.1016\/j.clml.2025.11.008_bib0009","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3324\/haematol.2023.282716","article-title":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","volume":"108","author":"Bisig","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2025.11.008_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ajcp\/aqaf020","article-title":"Epstein-Barr virus-positive T- and NK-cell lymphoproliferative disorders: report from the 2023 SH\/EA4HP lymphoma workshop","volume":"164","author":"Quintanilla-Martinez","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2025.11.008_bib0011","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.MP.0000036343.61268.64","article-title":"Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity","volume":"15","author":"Mukai","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2025.11.008_bib0012","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2012.04199.x","article-title":"Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases","volume":"61","author":"Kato","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.clml.2025.11.008_bib0013","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00428-023-03616-4","article-title":"Cytotoxic peripheral T-cell lymphomas and EBV-positive T\/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Climent","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clml.2025.11.008_bib0014","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/bloodadvances.2023012019","article-title":"EBV+ nodal T\/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome","volume":"8","author":"Kato","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2025.11.008_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/PAS.0000000000002184","article-title":"EBV-positive nodal T-cell and NK-cell lymphoma: a study of 26 cases including a subset with strong CD30 expression mimicking anaplastic large cell lymphoma","volume":"48","author":"Yu","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2025.11.008_bib0016","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2329136","article-title":"A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry","volume":"56","author":"Jin","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.clml.2025.11.008_bib0017","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3892\/ol.2012.754","article-title":"Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: report of a case with review of the literature","volume":"4","author":"Yoshii","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clml.2025.11.008_bib0018","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1159\/000537962","article-title":"Primary nodal Epstein-Barr virus-positive T-cell\/NK-cell lymphoma: real-world experience","volume":"147","author":"Choi","year":"2024","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2025.11.008_bib0019","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/cam4.494","article-title":"P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases","volume":"4","author":"Yoshimori","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.clml.2025.11.008_bib0020","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2025.11.008_bib0021","first-page":"1359","article-title":"Down-regulation of intracellular reactive oxygen species attenuates P-glycoprotein-associated chemoresistance in Epstein-Barr virus-positive NK\/T-cell lymphoma","volume":"11","author":"Nam","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.clml.2025.11.008_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1200\/JCO.1993.11.1.109","article-title":"Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors","volume":"11","author":"Cheng","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.11.008_bib0023","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1600-0463.2008.00974.x","article-title":"Immunohistochemical expression of multidrug resistance proteins in mature T\/NK-cell lymphomas","volume":"116","author":"Saglam","year":"2008","journal-title":"APMIS"},{"key":"10.1016\/j.clml.2025.11.008_bib0024","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1349-7006.2007.00549.x","article-title":"Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target","volume":"98","author":"Chuang","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clml.2025.11.008_bib0025","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell tumor study group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.11.008_bib0026","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00428-016-2011-0","article-title":"Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK\/T cell lymphoma is associated with better prognosis","volume":"469","author":"Kim","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clml.2025.11.008_bib0027","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/etm.2023.12294","article-title":"Expression of the immune checkpoint molecules PDL1 and PD1 in EBV-associated lymphoproliferative disorders: a metaanalysis","volume":"27","author":"Yu","year":"2024","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.clml.2025.11.008_bib0028","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4143\/crt.2018.191","article-title":"Comparison of efficacy of pembrolizumab between Epstein-Barr virus\u2012positive and \u2012negative relapsed or refractory non-Hodgkin lymphomas","volume":"51","author":"Kim","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clml.2025.11.008_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136476","article-title":"PD-1 blockade can restore functions of T-cells in Epstein-Barr virus-positive diffuse large B-cell lymphoma in vitro","volume":"10","author":"Quan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2025.11.008_bib0030","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41375-023-01924-x","article-title":"Allogeneic hematopoietic stem cell transplantation for NK\/T-cell lymphoma: an international collaborative analysis","volume":"37","author":"Berning","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.11.008_bib0031","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fped.2018.00334","article-title":"Hematopoietic stem cell transplantation for the treatment of Epstein-Barr virus-associated T- or NK-cell lymphoproliferative diseases and associated disorders","volume":"6","author":"Sawada","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clml.2025.11.008_bib0032","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajh.21247","article-title":"Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan","volume":"83","author":"Sato","year":"2008","journal-title":"Am J Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025042946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025042946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:41:43Z","timestamp":1780990903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025042946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2152265025042946"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.11.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dismal Outcome of EBV-Positive Nodal T\/NK-Cell Lymphoma: A Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}